Rising Road Accidents Fuel Growth In The Acute Spinal Cord Injury Market: A Key Factor Shaping the Future of the Acute Spinal Cord Injury Market in 2025

Which drivers are expected to have the greatest impact on the over the acute spinal cord injury market's growth?
Expectations for the acute spinal cord injury market's expansion revolve heavily around the surge in road accidents. Road accidents are usually characterized by a vehicle collision, leading to serious injuries or fatalities. Resultant accidental spinal injuries often adversely affect the central nervous system (CNS) and impede the functioning of vital nerves needed for sensory abilities. The impact severity can lead to trauma in the cervical, lumbar, or thoracic spine, damage or sever the spinal cord, and cause paralysis. For example, in June 2024, the Llywodraeth Cymru / Welsh Government reported a total of 4,348 road casualties in Wales in 2023, marking a 2% increase from 2022. This uptick in accidents contributes significantly to the growth of the acute spinal cord injury market. Acute Spinal Cord Injury Market Driver: Proliferation of Clinical Trials Spurs Advances in Acute Spinal Cord Injury Market

Get Your Acute Spinal Cord Injury Market Report Here:
https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

What is the future CAGR of the acute spinal cord injury market, and how will it impact industry expansion?
The market size for acute spinal cord injury has experienced significant growth in the past few years. It is predicted to increase from $6.7 billion in 2024 to around $7.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.6%. This growth observed in the past can be linked to an increase in incidences of acute spinal cord injuries, heightened awareness about the injury and its treatment options, a surge in demand for tailored care, a rise in disposable income levels, as well as an uptick in government expenditure on ASCI research and development.

In the coming years, the acute spinal cord injury market is projected to experience substantial growth, reaching $8.77 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 5.5%. This growth over the forecast period can be associated with the advent of new therapies, the uptake of telemedicine, models of care focused on the patient, and an intensified focus on preventive healthcare and prevention of injuries. Noteworthy trends in the forecast period are advancements in the medical field, techniques in rehabilitation, therapies for neuroprotection, psychosocial support, advocacy and accessibility.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12960&type=smp

What are the most significant trends transforming the acute spinal cord injury market today?
Leading firms in the acute spinal cord injury market are striving to create innovative medications to cater to their clients and maintain their market stance. This includes the launch of cutting-edge drugs like LYVISPAH, which can enhance results when used in combination therapies. For example, in July 2022, Amneal Pharmaceuticals, a pharmaceutical company based in the US, introduced LYVISPAH, an oral granule of baclofen (5, 10 and 20 mg) that has obtained approval from the U.S. Food and Drug Administration (FDA) for the management of spasticity associated with multiple sclerosis and various other spinal cord conditions. LYVISPAH can effectively treat and alleviate ailments like flexor spasms, tied discomfort, clones and muscle stiffness. It offers tailor-made dosage flexibility with single-dose granule packs in dosages of 5 mg, 10 mg, and 20 mg, and is biologically equivalent to oral baclofen tablets. Individuals suffering from spinal cord injuries and other such conditions can also gain from the use of LYVISPAH.

Which key market segments comprise the acute spinal cord injury market and drive its revenue growth?
The acute spinal cord injury market covered in this report is segmented -

1) By Type: Complete Spinal Cord Injury, Incomplete Spinal Cord Injury
2) By Diagnosis Type: Laboratory Tests, Imaging Tests
3) By Application: Hospitals, Clinics

Subsegments:
1) By Complete Spinal Cord Injury: Tetraplegia, Paraplegia
2) By Incomplete Spinal Cord Injury: Central Cord Syndrome, Anterior Cord Syndrome, Brown-Séquard Syndrome, Conus Medullaris Syndrome, Cauda Equina Syndrome

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12960

What regions are at the forefront of acute spinal cord injury market expansion?
North America was the largest region in the acute spinal cord injury market in 2024. The regions covered in acute spinal cord injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the leading players fueling growth in the acute spinal cord injury market?
Major companies operating in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12960&type=smp

What Is Covered In The Acute Spinal Cord Injury Global Market Report?

• Market Size Forecast: Examine the acute spinal cord injury market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the acute spinal cord injury market for a structured understanding.
• Key Players Overview: Analyze major players in the acute spinal cord injury market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the acute spinal cord injury market.
• Segment Contributions: Evaluate how different segments drive overall growth in the acute spinal cord injury market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the acute spinal cord injury market.
• Industry Challenges: Identify potential risks and obstacles affecting the acute spinal cord injury market.
• Competitive Landscape: Review strategic developments in the acute spinal cord injury market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.